According to Pfizer, studies suggest the vaccine is 91% effective against variants from South Africa – National

Pfizer and BioNTech announced Thursday that their COVID-19 vaccine is around 91 percent effective in preventing the disease, and cited updated study data that included participants who were vaccinated for up to six months.

The shot was also 100 percent effective in preventing disease among study participants in South Africa, where a new variant called B1351 dominates, although the number of those participants was relatively small at 800.

While the new overall effectiveness rate of 91.3 percent is lower than the 95 percent originally reported in November for the 44,000-person study, a number of variants have since spread around the world.

Continue reading:

According to Pfizer, the COVID-19 vaccine is 100% effective at protecting children ages 12 to 15 in the study

Albert Bourla, Pfizer’s chief executive officer, said the updated results, which include data on more than 12,000 people who have been fully vaccinated for at least six months, are prompting drug manufacturers to apply for full US approval.

The story continues under the advertisement

The vaccine is currently approved by the US Food and Drug Administration in an emergency.

The study data “provides the first clinical results that a vaccine can effectively protect against currently circulating variants, a crucial factor in achieving herd immunity and ending this pandemic for the world population,” said Ugur Sahin, CEO of BioNTech, in a statement .

Trend stories

  • 4 Dead, Including Child, in Gunfire in Southern California: Reports

  • The Ontario government is trying to activate the 4-week, nationwide COVID-19 emergency brake.


Click here to play the video:


2:36
COVID-19: According to Pfizer, the vaccine is 100% effective at protecting children between the ages of 12 and 15, according to the study


COVID-19: According to Pfizer, the vaccine is 100% effective at protecting children between the ages of 12 and 15, according to the study

Experts fear that new variants of COVID-19 from South Africa and Brazil could be resistant to existing vaccines and treatments. According to federal data, more than 300 cases of the South African variant have been discovered in more than 25 states and jurisdictions.

The vaccine was 100% effective in preventing major diseases as defined by the U.S. Centers for Disease Control and Prevention and 95.3 percent effective in preventing major diseases as defined by the U.S. Food and Drug Administration Drug Administration Defined.

The story continues under the advertisement

Up to six months after the second dose, the study participants also did not have any serious safety concerns, the companies said.

Continue reading:

Real-world data shows that Pfizer, Moderna vaccines are highly effective after just one shot

They added that it was generally equally effective regardless of age, race, gender, or ethnicity, and in participants with a variety of pre-existing medical conditions.

The study looked at more than 900 confirmed cases of COVID-19, most of which were among those who received a placebo.

The publication of updated results follows separate data showing the vaccine is safe and effective in 12-15 year olds. This paves the way for drug manufacturers to seek US and European approval to use the shot in this age group for weeks.

Show link »

Comments are closed.